Patrys Limited (ASX:PAB)
0.0450
+0.0030 (7.14%)
May 29, 2026, 3:47 PM AEST
Patrys Market Cap
Patrys has a market cap or net worth of 30 million as of May 29, 2026. Its market cap has increased by 629.03% in one year.
Market Cap
30.00M
Enterprise Value
28.09M
Revenue
100.38K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since July 13, 2007, Patrys's market cap has decreased from 97.06M to 30.00M, a decrease of -69.09%. That is a compound annual growth rate of -6.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 30.00M | 214.43% |
| Dec 31, 2025 | 9.54M | 15.93% |
| Dec 31, 2024 | 8.23M | -50.00% |
| Dec 29, 2023 | 16.46M | -70.36% |
| Dec 30, 2022 | 55.54M | -27.00% |
| Dec 31, 2021 | 76.08M | 75.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entropy Neurodynamics | 53.85M |
| Nexsen | 50.05M |
| Imugene | 47.82M |
| Neurizon Therapeutics | 46.27M |
| Avecho Biotechnology | 45.97M |
| NeuroScientific Biopharmaceuticals | 30.60M |
| EZZ Life Science Holdings | 29.75M |
| Noxopharm | 26.42M |